Inactive Instrument

Highlights Caplin Point Laboratories Ltd NSE India S.E.

Equities

INE475E01018

End-of-day quote NSE India S.E. Other stock markets
- ^INR	-

05-24	Caplin Point Arm Gets US FDA's Nod for Phenylephrine Hydrochloride Ophthalmic Solution	MT
05-16	Caplin Point Laboratories to Seek Acquisitions	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Ex-dividend day for interim dividend	05-30	FA
Caplin Point Laboratories to Seek Acquisitions	05-16	CI
Caplin Point Laboratories Limited Declares an Interim Dividend for the Financial Year Ended March 31, 2024	05-16	CI
Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-16	CI
Caplin Point Laboratories Gets Colombian Drug Regulator's Approval for Soft Gel Capsules Unit in India	05-06	MT
Caplin Point Laboratories Limited Receives Colombia's INVIMA Approval for Its Softgel Capsules Division At Puducherry	05-06	CI
Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution	04-16	MT
Caplin Steriles Limited, A Subsidiary of Caplin Point Laboratories Limited Gets USFDA Approval for Ketorolac Tromethamine Ophthalmic Solution	03-28	CI
Caplin Point Laboratories Arm Starts Operations of Oncology Facility at Kakkalur, India	03-27	MT
Caplin One Labs Limited, a Wholly Owned Subsidiary of Caplin Point Laboratories Limited Successfully Completes New Oncology (Anti-Cancer) Facility, Commences Operations	03-27	CI
Caplin Point Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-09	CI
Caplin Point Laboratories to Invest INR7 Billion in Tamil Nadu, India	01-08	MT
Caplin Point Unit Gets US FDA Final Approval for Generic Ear Infection Drug	01-08	MT
Caplin Point Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-09	CI
Caplin Point Laboratories Limited Approves Final Dividend for the Year Ended March 31, 2023	23-09-22	CI
Final dividend	23-09-13	FA
Caplin Point Unit's Injectable and Ophthalmic Plant in India Gets VAI Classification from US FDA	23-09-04	MT
Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-07	CI
Caplin Point Laboratories Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023	23-08-07	CI
Caplin Point Laboratories to Incorporate Step-Down Subsidiary in US	23-08-03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Caplin Point Laboratories Ltd NSE India S.E.

Equities

INE475E01018

Highlights

Filters